Retinal Diseases
47
6
9
27
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.4%
3 terminated out of 47 trials
90.0%
+3.5% vs benchmark
11%
5 trials in Phase 3/4
22%
6 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (47)
Defining Retinal Structures Using Hyperspectral Retinal Imaging
4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800
SGLT2 Inhibitors in Geographic Atrophy
Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy
Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
DISCOVER Study: Microscope-integrated Intraoperative OCT Study
Arterial Spin Labeling MRI for Assessing Blood Perfusion in the Human Eye Repeatability Study and Clinical Application
An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD
Evaluation of Diabetic Retinopathy Using Ultra-Widefield Fundus Images Compared With Two-Field Fundus Images
Clinical Investigation of a New Version of MAIA Microperimeter on Healthy Subjects and Patients With Retinal Pathology
Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
Evaluating the Safety of the SPECTRALIS CENTAURUS Device
Real-world of AI in Diagnosing Retinal Diseases
Long-shaft Vitrectomy Probe in Highly Myopic Eyes
Pistachios and Neural Macular Pigment
Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration